Rivus Pharmaceuticals
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
2
Funding Rounds
$167.0m
Money raised
Overview
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Al*** Cu*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Rivus Pharmaceuticals has raised a total of $167m in funding over 2 rounds.
Key Insights:
- Rivus Pharmaceuticals - Series B round, September 2022: $132m
- Rivus Pharmaceuticals Series A round, July 2021: $35m
Rivus Pharmaceuticals - Series B round, September 2022
$132m
Rivus Pharmaceuticals Series A round, July 2021
$35m
Industries
Rivus Pharmaceuticals is active in the following industries: